25% of MTCs are of hereditary origin, which is related to the RET proto-oncogene, most occurs as part of multiple endocrine neoplasia (MEN) 2 syndrome, and the remaining occur as sporadic forms [2]. Here, RET is linked to multiple endocrine neoplasia.